What Do I Need to Know About SARMs?
Understanding SARMs
Selective Androgen Receptor Modulators (SARMs) are compounds developed to address health issues associated with low testosterone levels due to aging or hormonal imbalances. Unlike traditional testosterone treatments, SARMs aim to minimize side effects. However, they are classified as drugs, not supplements, and remain unapproved by the FDA for safety and efficacy in the U.S. Despite this, online sellers often promote them as quick solutions for bodybuilders and fitness enthusiasts. It is important to note that SARMs, like anabolic steroids, can lead to adverse effects.
What Are SARMs?
SARMs have gained traction within fitness and bodybuilding circles as a new category of performance-enhancing substances. They promise muscle growth and fat loss with fewer side effects than conventional anabolic steroids. However, their increasing popularity raises concerns regarding safety, legality, and long-term health consequences.
These synthetic compounds selectively target androgen receptors in specific tissues, aiming to replicate testosterone benefits, such as muscle mass increase, while reducing side effects associated with steroids, including prostate enlargement and hair loss.
Key Types of SARMs
Several SARMs have emerged in the fitness community and undergone clinical trials:
– **Ostarine (MK-2866 or enobosarm):** Well-researched, showing promise in increasing lean body mass.
– **Ligandrol (LGD-4033):** Known for its strong anabolic effects.
– **Testolone (RAD-140):** Notable for its high selectivity for androgen receptors in muscle and bone.
– **Andarine (S-4):** Initially developed for treating osteoporosis and muscle wasting.
Evaluating SARMs: Insights from Clinical Research
Efficacy of SARMs
A 2022 systematic review published in the Journal of Xenobiotics analyzed 18 clinical studies involving 2,136 patients, with 1,447 exposed to a SARM. Among these studies, five focused on drug efficacy. Results were mixed; for instance, MK-0773 improved lean body mass in frail elderly women, although it did not enhance strength. GTx-024 showed better outcomes, aiding elderly men and postmenopausal women in gaining lean body mass and improving physical function. Conversely, LY900010, aimed at treating erectile dysfunction, proved ineffective.
A 21-day study on Ligandrol, reported in the Journal of Gerontology, indicated increased lean body mass and leg press strength in healthy young men, accompanied by mild side effects such as headaches and dry mouth. Despite over a decade of trials, no SARMs have reached the market, highlighting ongoing research challenges.
Safety Concerns Surrounding SARMs
While efficacy data may be inconclusive, all 18 clinical trials from the 2022 review reported adverse events and side effects, including:
– Jaundice, indicating liver issues
– Increased blood pressure
– Reduced testosterone levels
– Shrinking testicles
– Acne
– Elevated hemoglobin/hematocrit
– Headaches
– Dry mouth
– Upper respiratory infections
– Constipation
– Dyspepsia
– Nausea
Regulatory Stance on SARMs
FDA Warnings
The FDA has issued serious warnings regarding SARMs, citing potential health risks such as liver damage, heightened risk of heart attack and stroke, and hormonal disruption. Currently, SARMs cannot be legally marketed in the U.S. as dietary supplements or drugs, and the FDA continues to receive adverse event reports related to these substances.
A notable case in the journal Hepatology detailed a 24-year-old male bodybuilder who developed liver injury after using Ligandrol purchased online, resulting in jaundice and elevated liver enzymes.
Black Market and Legal Issues
Despite regulatory efforts, a robust black market for SARMs persists. Many online vendors exploit legal loopholes, marketing SARMs as “research chemicals” to evade regulations. A study in JAMA found that only 52% of products marketed as SARMs contained actual SARMs, with many containing unapproved drugs or substances not disclosed on their labels.
Personal Stories and Experiences
Cautionary Tales
The allure of SARMs has attracted various users, each with unique experiences.
**Tim’s Story:** A 30-year-old fitness enthusiast shared his cautionary tale through the Therapeutic Goods Administration of Australia. After purchasing SARMs online, Tim experienced severe side effects, including mood swings and testicular pain. He reflects, “I thought SARMs were a safer option compared to steroids, but I ended up with severe mood swings and testicular pain.”
**The Athlete’s Dilemma:** CrossFit athlete Ricky Garard tested positive for Ligandrol in 2019, leading to the loss of his bronze medal from the 2017 CrossFit Games. He had believed he was using a legal supplement, showcasing the complexities athletes face regarding performance enhancement. “I thought I was taking a legal supplement, but it turned out to be a banned substance. The consequences were devastating,” Garard stated.
Consultation with Healthcare Providers
As SARM usage increases, healthcare providers are positioned to educate and reduce harm. The FDA encourages consumers to discuss any products aimed at increasing muscle mass or enhancing athletic performance with medical professionals. Steve Mister from the Council for Responsible Nutrition emphasizes, “SARMs are not legitimate dietary supplements; they are unapproved drugs.”
Future Considerations Beyond SARMs
As interest in SARMs continues, another class of performance-enhancing substances, peptides, is gaining attention. These short chains of amino acids are being investigated for their potential in muscle growth, recovery, and athletic performance. One peptide, BPC-157, is noted for its ability to accelerate wound healing and tissue repair, though human trials remain limited.
Similar to SARMs, the long-term effects and safety profile of peptides like BPC-157 in healthy individuals are not well established. While they may offer promising potential for performance enhancement, they also present risks and legal considerations.
References
– Papanicolaou DA, et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. The Journal of Nutrition, Health and Aging.
– Solomon ZJ, et al. Selective Androgen Receptor Modulators (SARMs) – Current Knowledge and Clinical Applications. Sex Med Rev.
– Vignali JD, et al. Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users. Journal of Xenobiotics.
– Dalton JT, et al. The selective androgen receptor modulator GTx-024 improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle.
– Basaria S, et al. The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men. J Gerontol A Biol Sci Med Sci.
– FDA Warns of Use of Selective Androgen Receptor Modulators (SARMs) Among Teens and Young Adults. U.S. Food and Drug Administration.
– Barbara M, et al. Drug induced liver injury caused by “legal steroids”: A case report. World J Hepatol.
– Van Wagoner RM, et al. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA.
– Consumer story: Tim and selective androgen receptor modulators (SARMs). Therapeutic Goods Administration.
– CrossFit Athlete Ricky Garard Admits to Taking SARMs, Stripped of 2017 Games Medal. BarBend.
– Selective Androgen Receptor Modulators (SARMs): What You Need to Know. Council for Responsible Nutrition.
– Chang CH, et al. Oral administration of BPC-157 enhances healing of muscle and tendon injuries in rats. J Physiol Sci.